- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/765 - Serum albumin, e.g. HSA
Patent holdings for IPC class C07K 14/765
Total number of patents in this class: 629
10-year publication summary
|
68
|
44
|
56
|
46
|
53
|
42
|
58
|
42
|
56
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4872 |
15 |
| Sartorius Albumedix Limited | 47 |
15 |
| JCR Pharmaceuticals Co., Ltd. | 221 |
14 |
| Wuhan Healthgen Biotechnology Corp | 29 |
9 |
| Novozymes Biopharma DK A/S | 25 |
9 |
| Sanofi Aatd Inc. | 17 |
9 |
| MedImmune, LLC | 495 |
8 |
| Janssen Biotech, Inc. | 1550 |
7 |
| Silver Creek Pharmaceuticals, Inc. | 29 |
7 |
| Shenzhen Protgen Ltd. | 10 |
7 |
| CSL Limited | 256 |
6 |
| Glytech, Inc. | 65 |
6 |
| Healthgen Biotechnology Co., Ltd. | 6 |
6 |
| Regeneron Pharmaceuticals, Inc. | 4303 |
6 |
| University of Oslo | 45 |
6 |
| Zymeworks Inc. | 258 |
6 |
| The Johns Hopkins University | 5689 |
5 |
| Ablynx N.V. | 398 |
5 |
| National Research Council of Canada | 1545 |
5 |
| Novartis AG | 10727 |
4 |
| Other owners | 474 |